A novel efficient HBV vaccine candidate based on HBc and preS1 components presented by VLPs
A novel efficient HBV vaccine candidate based on HBc and preS1 components presented by VLPs. Andris Dišlers 24.05.2016. Symposium: TARGETS OF IMMUNOTHERAPY OF CHRONIC VIRAL INFECTIONS AND CANCER Rīga Stradiņš University, Dzirciema iela 16, Rīga, Latvia Senate Hall, Block K.
268 views • 26 slides